doi:10.3969/j.issn.1004-583X.2021.05.016

Abstract

CLC Number:

R574.62

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.05.016

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I5/467

References 30

[1]	Lacy BE, Mearin F, Chang L, et al. Bowel disorders[J]. Gastroenterology, 2016 150(6):1393-1407. doi: 10.1053/j.gastro.2016.02.031 URL
[2]	Beckers AB, Weerts ZZRM, Helyes Z, et al. Review article: Transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome[J]. Aliment Pharmacol Ther, 2017, 46(10):938-952. doi: 10.1111/apt.14294 URL
[3]	Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome[J]. N Engl J Med, 2017, 376(26):2566-2578. doi: 10.1056/NEJMra1607547 URL
[4]	Akbar A, Yiangou Y, Facer P, et al. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain[J]. Gut, 2010, 59(6):767-774. doi: 10.1136/gut.2009.194449 URL
[5]	Lee JY, Kim N, Park JH, et al. Expression of neurotrophic factors, tight junction proteins, and cytokines according to the irritable bowel syndrome subtype and sex[J]. J Neurogastroenterol Motil, 2020, 26(1):106-116. doi: 10.5056/jnm19099 URL
[6]	Weerts ZZRM, Keszthelyi D, Vork L, et al. A novel ileocolonic release peppermint oil capsule for treatment of irritable bowel syndrome: A phase i study in healthy volunteers[J]. Adv Ther, 2018, 35(11):1965-1978. doi: 10.1007/s12325-018-0802-1 pmid: 30284674
[7]	Yu X, Yu M, Liu Y, et al. TRP channel functions in the gastrointestinal tract[J]. Semin Immunopathol, 2016, 38(3):385-396. doi: 10.1007/s00281-015-0528-y URL
[8]	Khalil M, Alliger K, Weidinger C, et al. Functional role of transient receptor potential channels in immune cells and epithelia[J]. Front Immunol, 2018, 9:174. doi: 10.3389/fimmu.2018.00174 URL
[9]	Balemans D, Boeckxstaens GE, Talavera K, et al. Transient receptor potential ion channel function in sensory transduction and cellular signaling cascades underlying visceral hypersensitivity[J]. Am J Physiol Gastrointest Liver Physiol, 2017, 312(6):G635-G648. doi: 10.1152/ajpgi.00401.2016 URL
[10]	Masui K, Terada Y, Tsubota M, et al. Tacrolimus, a calcineurin inhibitor, promotes capsaicin-induced colonic pain in mice[J]. J Pharmacol Sci, 2020, 143(1):60-63. doi: 10.1016/j.jphs.2020.01.006 URL
[11]	Balemans D, Boeckxstaens GE, Talavera K, et al. Transient receptor potential ion channel function in sensory transduction and cellular signaling cascades underlying visceral hypersensitivity[J]. Am J Physiol Gastrointest Liver Physiol, 2017, 312(6):G635-G648. doi: 10.1152/ajpgi.00401.2016 URL
[12]	Pisipati S, Connor BA, Riddle MS. Updates on the epidemiology, pathogenesis, diagnosis, and management of postinfectious irritable bowel syndrome[J]. Curr Opin Infect Dis, 2020, 33(5):411-418. doi: 10.1097/QCO.0000000000000666 pmid: 32833689
[13]	Bortolotti M, Porta S. Effect of red pepper on symptoms of irritable bowel syndrome: Preliminary study[J]. Dig Dis Sci, 2011, 56(11):3288-3295. doi: 10.1007/s10620-011-1740-9 URL
[14]	Szymaszkiewicz A, Włodarczyk J, Wasilewski A, et al. Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: Characterization of the action of palvanil in the mouse gastrointestinal tract[J]. Naunyn Schmiedebergs Arch Pharmacol, 2020, 393(8):1357-1364. doi: 10.1007/s00210-020-01829-x URL
[15]	McGuire C, Boundouki G, Hockley JRF, et al. Ex vivo study of human visceral nociceptors[J]. Gut, 2018, 67(1):86-96. doi: 10.1136/gutjnl-2016-311629 pmid: 27654583
[16]	Cenac N, Bautzova T, Le Faouder P, et al. Quantification and potential functions of endogenous agonists of transient receptor potential channels in patients with irritable bowel syndrome[J]. Gastroenterology, 2015, 149(2):433-447. doi: 10.1053/j.gastro.2015.04.011
[17]	Balemans D, Aguilera-Lizarraga J, Florens MV, et al. Histamine-mediated potentiation of transient receptor potential (TRP) ankyrin 1 and TRP vanilloid 4 signaling in submucosal neurons in patients with irritable bowel syndrome[J]. Am J Physiol Gastrointest Liver Physiol, 2019, 316(3):G338-G349. doi: 10.1152/ajpgi.00116.2018 URL
[18]	Souza Monteiro de Araujo D, Nassini R, Geppetti P, et al. TRPA1 as a therapeutic target for nociceptive pain[J]. Expert Opin Ther Targets, 2020, 24(10):997-1008. doi: 10.1080/14728222.2020.1815191 URL
[19]	Hassan AA, Sleet B, Cousins Z, et al. TRPA1 channel activation inhibits motor activity in the mouse colon[J]. Front Neurosci, 2020, 14:471. doi: 10.3389/fnins.2020.00471 URL
[20]	Chen X, Luo QQ, Yan XJ, et al. Vagal transient receptor potential ankyrin 1 mediates stress-exacerbated visceral mechanonociception after antral cold exposure[J]. J Neurogastroenterol Motil, 2019, 25(3):442-460. doi: 10.5056/jnm19014 URL
[21]	Ordás P, Hernández-Ortego P, Vara H, et al. Expression of the cold thermoreceptor TRPM8 in rodent brain thermoregulatory circuits[J]. J Comp Neurol, 2021, 529(1):234-256. doi: 10.1002/cne.v529.1 URL
[22]	Ramachandran R, Hyun E, Zhao L, et al. TRPM8 activation attenuates inflammatory responses in mouse models of colitis[J]. Proc Natl Acad Sci USA, 2013, 110(18):7476-7481. doi: 10.1073/pnas.1217431110 URL
[23]	González-Muñizá R, Bonache MA, Martín-Escura C, et al. Recent progress in TRPM8 modulation: An update[J]. Int J Mol Sci, 2019, 20(11):2618. doi: 10.3390/ijms20112618 URL
[24]	Typolt O, Filingeri D. Evidence for the involvement of peripheral cold-sensitive TRPM8 channels in human cutaneous hygrosensation[J]. Am J Physiol Regul Integr Comp Physiol, 2020, 318(3):R579-R589. doi: 10.1152/ajpregu.00332.2019 URL
[25]	Mueller-Tribbensee SM, Karna M, Khalil M, et al. Differential contribution of TRPA1, TRPV4 and TRPM8 to colonic nociception in mice[J]. PLoS One, 2015, 10(7):e0128242.
[26]	Henström M, Hadizadeh F, Beyder A, et al. TRPM8 polymorphisms associated with increased risk of IBS-C and IBS-M[J]. Gut, 2017, 66(9):1725-1727. doi: 10.1136/gutjnl-2016-313346 pmid: 27974553
[27]	Luo QQ, Wang B, Chen X, et al. Acute stress induces visceral hypersensitivity via glucocorticoid receptor-mediated membrane insertion of TRPM8: Involvement of a non-receptor tyrosine kinase Pyk2[J]. Neurogastroenterol Motil, 2020, 32(10):1514-1528.
[28]	中华医学会消化病学分会胃肠功能性疾病协作组; 中华医学会消化病学分会胃肠动力学组. 中国肠易激综合征专家共识意见(2015年,上海)[J]. 中华消化杂志, 2016, 36(5):299-312.
[29]	Ford AC, Moayyedi P, Chey WD, et al. American college of gastroenterology monograph on management of irritable bowel syndrome[J]. Am J Gastroenterol, 2018, 113(Suppl 2):1-18.
[30]	Black CJ, Ford AC. Global burden of irritable bowel syndrome: Trends, predictions and risk factors[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(8):473-486. doi: 10.1038/s41575-020-0286-8 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 30

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhang Xiumin, Zhao Changdong, Li Xue, Lu Xuefeng, Liu Weizhong, Wang Shufang. Relationship between indoleamine 2, 3-dioxygenase and peripheral blood CD4 + in patients with ulcerative colitis [J]. Clinical Focus, 2021, 36(8): 696-698.
[2]	Song Yiran, Liang Xiaonan, Li Chenyang, Zhang Xiaolan. Interpretation on Chinese Expert Consensus of Irritable Bowel Syndrome in 2020 [J]. Clinical Focus, 2021, 36(7): 628-631.
[3]	. [J]. Clinical Focus, 2015, 30(9): 1056-1059.
[4]	ZHENG Xiu-li;FU Xue-song;WANG Yu-gang;ZHANG Yan-hua;ZHAO Xia;LI Hong-yin. Effect of otilonium bromide combined with probiotics for diarrhea-predominant irritable bowel syndrome [J]. Clinical Focus, 2014, 29(10): 1168-1170.
[5]	WU Xiao-lei;ZHU Fang-li;LV Xiao-min;SONG Jia;ZHANG Xiao-lan. Association of CYP27B1 gene promoter polymorphism with ulcerative colitis [J]. CLINICAL FOCUS, 2013, 28(11): 1249-1251.
[6]	LIU Lei;ZHANG Hong;NIU Guo-chao;WU Hui;LI Hui;ZHANG Xiao-lan. Effect of human umbilical cord mesenchymal stem cells on cycloxygenase-2 expression in dextran sodium sulfate-induced chronic colitis [J]. CLINICAL FOCUS, 2013, 28(7): 763-0.
[7]	. [J]. Clinical Focus, 2013, 28(4): 464-467.
[8]	XU Guang-hui;QIU Min-jie;LING Guo-min;LI Hui-min;LIU Bin;WANG Ze-yan. Relation between melanosis coli and expression of oncogene as well as its clinical significance [J]. CLINICAL FOCUS, 2013, 28(3): 294-297.
[9]	. [J]. CLINICAL FOCUS, 2013, 28(3): 318-319.
[10]	LV Fei;LU Guang-xin;DU Yong. Effects of compound glycyrrhizin on serum expression of interleukin 4, interleukin 7 level in experimental ulcerative colitis of rats [J]. Clinical Focus, 2013, 28(2): 178-180.
[11]	. [J]. Clinical Focus, 2012, 27(23): 2109-2112.
[12]	. [J]. Clinical Focus, 2012, 27(17): 1534-1535.
[13]	. [J]. Clinical Focus, 2012, 27(13): 1147-1149.
[14]	. [J]. Clinical Focus, 2012, 27(12): 1053-0.
[15]	. [J]. Clinical Focus, 2012, 27(6): 546-547.